suramin has been researched along with globotriaosylceramide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arvidsson, I; Hedström, MM; Karpman, D; Kristoffersson, AC; Olsson, ML; Rylander, C; Ståhl, AL; Storry, JR; Westman, JS | 1 |
1 other study(ies) available for suramin and globotriaosylceramide
| Article | Year |
|---|---|
Shiga toxin-induced complement-mediated hemolysis and release of complement-coated red blood cell-derived microvesicles in hemolytic uremic syndrome.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Child; Child, Preschool; Coated Vesicles; Complement Activation; Complement C3; Complement C9; Complement Membrane Attack Complex; Edetic Acid; Erythrocytes; Escherichia coli Infections; Escherichia coli O157; Female; Gene Expression; Hemolysis; Hemolytic-Uremic Syndrome; Humans; Infant; L-Lactate Dehydrogenase; Male; Middle Aged; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Shiga Toxin; Suramin; Trihexosylceramides | 2015 |